NLSP

NLS Pharmaceutics Ltd.

0.28 USD
+0.13 (+86.78%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

NLS Pharmaceutics Ltd. stock is up 53.89% since 30 days ago. The next earnings date is Jul 2, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 June’s closed higher than May.

About NLS Pharmaceutics Ltd.

NLS Pharmaceutics AG is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders. Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy. The company was incorporated in 2015 and is based in Zurich, Switzerland.